Lucira Health, Inc.
CIK:0001652724|SEC Filings
CONDENSED STATEMENTS OF OPERATIONS (Unaudited) - USD ($) |
3 Months Ended | 9 Months Ended | ||
|---|---|---|---|---|
Sep. 30, 2022 |
Sep. 30, 2021 |
Sep. 30, 2022 |
Sep. 30, 2021 |
|
| Income Statement [Abstract] | ||||
| Net sales | $ 34,390,000 | $ 14,976,000 | $ 151,010,000 | $ 31,931,000 |
| Cost of products sold | 133,945,000 | 14,837,000 | 202,657,000 | 32,710,000 |
| Impairment of long-lived assets | 1,622,000 | 1,622,000 | ||
| Gross loss | (99,555,000) | (1,483,000) | (51,647,000) | (2,401,000) |
| Operating expenses: | ||||
| Research and development | 9,141,000 | 14,342,000 | 32,089,000 | 30,741,000 |
| Selling, general and administrative | 17,596,000 | 11,788,000 | 50,133,000 | 23,988,000 |
| Total operating expenses | 26,737,000 | 26,130,000 | 82,222,000 | 54,729,000 |
| Loss from operations | (126,292,000) | (27,613,000) | (133,869,000) | (57,130,000) |
| Other income (expense), net: | ||||
| Interest income and other (expense), net | 393,000 | 117,000 | 736,000 | 399,000 |
| Interest expense, net | (949,000) | (2,312,000) | (281,000) | |
| Total other income (expense), net | (556,000) | 117,000 | (1,576,000) | 118,000 |
| Loss before provision for income taxes | (126,848,000) | (27,496,000) | (135,445,000) | (57,012,000) |
| Provision for income taxes | 14,000.0 | 16,000.0 | ||
| Net loss | $ (126,862,000) | $ (27,496,000) | $ (135,461,000) | $ (57,012,000) |
| Net loss per share of common stock, | ||||
| Basic | $ (3.15) | $ (0.71) | $ (3.39) | $ (1.71) |
| Diluted | $ (3.15) | $ (0.71) | $ (3.39) | $ (1.71) |
| Weighted-average number of shares used in net loss per share of common stock, | ||||
| Basic | 40,216,244 | 38,667,615 | 39,974,997 | 33,348,104 |
| Diluted | 40,216,244 | 38,667,615 | 39,974,997 | 33,348,104 |